U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H14N2O2S
Molecular Weight 334.392
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TIDEGLUSIB

SMILES

O=C1SN(C(=O)N1CC2=CC=CC=C2)C3=CC=CC4=C3C=CC=C4

InChI

InChIKey=PMJIHLSCWIDGMD-UHFFFAOYSA-N
InChI=1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2

HIDE SMILES / InChI
Molecular Formula C19H14N2O2S
Molecular Weight 334.392
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:25:10 UTC 2023
Edited
by admin
on Fri Dec 15 17:25:10 UTC 2023
Record UNII
Q747Y6TT42
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TIDEGLUSIB
INN   WHO-DD  
INN  
Official Name English
4-BENZYL-2-(A-NAPHTHYL)-1,2,4-THIADIAZOLIDINE-3,5-DIONE
Common Name English
NP-031112
Code English
NP-12
Code English
4-BENZYL-2-(A-NAPHTYL)-1,2,4-THIADIAZOLIDINE-3,5-DIONE
Common Name English
4-BENZYL-2-(NAPHTHALEN-1-YL)-1,2,4-THIADIAZOLIDINE-3,5-DIONE
Systematic Name English
tideglusib [INN]
Common Name English
NP031112
Code English
Tideglusib [WHO-DD]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/15/1452
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
FDA ORPHAN DRUG 290109
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
FDA ORPHAN DRUG 577417
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
NCI_THESAURUS C471
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
Code System Code Type Description
PUBCHEM
11313622
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
DRUG BANK
DB12129
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
EPA CompTox
DTXSID90235682
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
SMS_ID
100000177254
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
NCI_THESAURUS
C97364
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
ChEMBL
CHEMBL3545157
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
INN
9223
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
FDA UNII
Q747Y6TT42
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
CAS
865854-05-3
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
WIKIPEDIA
Tideglusib
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
CHEBI
147398
Created by admin on Fri Dec 15 17:25:10 UTC 2023 , Edited by admin on Fri Dec 15 17:25:10 UTC 2023
PRIMARY
Related Record Type Details
GLYCOGEN SYNTHASE KINASE-3 BETA
TARGET -> INHIBITOR
IRREVERSIBLE INHIBITOR
Related Record Type Details
Structure of TIDEGLUSIB
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966